Delivery Order SPE2DB22D1202-SPE2DB24FUTW7
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,848.65 contract is for the supply of a pharmaceutical product, Clindamycin 900 mg/50 ml-D5W 50 ml. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,866.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564109642 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,389.20 firm fixed price delivery order contract to provide 4563616605 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML. This delivery order is issued under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the provision of Clindamycin 600mg medication, with a total potential value of $3,398.46 and a period of performance through February 12, 2024. This delivery order is issued under a larger, single-award indefinite delivery contract (IDC) held by...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,348.34 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,327,564 units of Clindamycin Phosphate 1% Lotion in 60 mL containers. This order is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific pharmaceutical product - Clindamycin 900 mg/50 ml-D5W 50 ml. The contract has a firm fixed price of $3,734.82 and a period of performance through June 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,634.84, is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract has a completion date of December 12, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,989.17 delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 900 mg/50 ml in dextrose 5% water solution. This competitively awarded, firm fixed price contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a child delivery order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUTW7Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,563,979,396 units of the pharmaceutical product Clindamycin 600 mg/50 ml-D5W 50 ml. The $1,198.76 contract has a performance period through March 18, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to support the Department of Defense. This delivery order contract does not have a set-aside designation.
Generated 6/14/24, 9:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 3/15/24 |